AI estimates retinal age, revealing sex-specific ageing patterns and links to disease risk
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Oct-2026 03:17 ET (28-Oct-2026 07:17 GMT/UTC)
Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, led the development of a new, investigational blood test that could detect pancreatic cancer at its earliest stages, when the disease is more treatable and potentially curable.
One reason pancreatic cancer remains so deadly is because it’s usually discovered late, after it has spread. A large, international study, published in Nature Medicine today, found that this liquid biopsy, called PANXEON*, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The experimental test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops.